全球肛門癌及大腸癌的全球市場:2022年～2028年

全球肛門癌及大腸癌的市場規模在預測期間內預計將以2.8％的年複合成長率擴大。肥胖和吸煙等生活方式障礙增加了肛門癌和結直腸癌的患病率，對其治療的需求正在推動市場增長。

本報告提供全球肛門癌及大腸癌市場相關調查，提供市場概要，以及各治療類型，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

第3章 競爭情形

• 主要企業分析
  • 概要
  • 財務分析
  • SWOT分析
  • 最近的開發
• 主要策略分析

第4章 市場決策要素

• 促進因素
• 阻礙因素
• 機會

第5章 市場區隔

• 全球肛門癌及大腸癌市場，各治療類型
  • 手術
  • 放射治療
  • 化療
  • 標靶治療
  • 免疫療法
• 全球肛門癌及大腸癌市場，各終端用戶
  • 醫院
  • 門診病人手術中心
  • 癌症研究中心

第6章 地區分析

• 北美
• 歐洲
• 亞太地區
• 其他地區

第7章 企業簡介

• Abbott Laboratories(Abbott Diagnostics)
• Advaxis, Inc.
• Amgen Inc.
• Atara Biotherapeutics, Inc.
• Bayer AG
• Beckman Coulter, Inc.
• Boehringer Ingelheim International GmbH
• Clinical Genomics Technologies Pvt. Ltd.
• EDP Biotech Corp.
• Eli Lilly and Co.**List not exhaustive

Global Anal and Colorectal Cancer Market Size, Share & Trends Analysis Report By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, and Immunotherapy), By End-User (Hospitals, Ambulatory Surgery Centers, and Cancer Research Centers) Forecast Period 2021-2027

The global anal and colorectal cancer market is anticipated to grow at a considerable CAGR of 2.8% during the forecast period. Anal and colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in the anus in the case of anal cancer. The rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has created a demand for its treatment which in turn is driving the market growth. Colorectal cancer is the third most common malignancy and the fourth leading cause of cancer-related mortalities globally. As per the World Health Organization (WHO), in 2020, the number of colorectum cancer of mortality of male and female of all ages was around 935,173 across the globe, which is 9.4% of total mortalities. Additionally, the number of new colorectum cancer patients of both sexes of all ages in 2020 was around 1.9 million globally, which is 10.0% of new cancer cases.

As per the American Cancer Society, around 9,090 new cases of anal cancer are expected in the US in 2021, of which 6,070 in women and 3,020 in men. Besides, around 1,430 mortalities of anal cancer are expected in 2021. Apart from it, around 104,270 new cases of colon cancer and around 45,230 new cases of rectal cancer are expected in the US in 2021. Furthermore, the increasing geriatric population which is more prone to colorectal cancer is another factor driving the market growth. However, the high cost of anal and colorectal cancer treatment along with low awareness towards this type of cancer act as major restraints for the market growth. However, increasing healthcare expenditure, technological advancement for cancer treatment, and rising demand for anal and colorectal cancer treatment are expected to drive the market especially in developing countries.

Segmental Outlook

The global anal and colorectal cancer market is segmented based on treatment and end-user. Based on the treatment, the market is segmented into surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Based on end-users the market is segmented into hospitals, ambulatory surgery centers, and cancer research centers. Hospitals held a major market share in 2020 based on end-user. The factors such as rising quality assessment in hospitals, growing colorectal cancer cases among individuals, and increasing demand for minimal complication rates in surgery of special colorectal cancer are anticipating to drive the growth of this market segment.

Global Anal and Colorectal Cancer Market Share by Treatment, 2020 (%)

Global Anal and Colorectal Cancer Market Share by Treatment

Surgery Segment holds the Significant share in the Market

The surgery segment held the highest share in 2020 and is also anticipated to grow during the forecast period. Surgery is done for the removal of the tumor and some surrounding healthy tissue during an operation. This is known as surgical resection. Surgery is the most common and widely used treatment for colorectal cancer. During surgery, a part of the healthy colon or rectum and nearby lymph nodes will be removed. When the colon cancer is very small then minimally invasive surgery will be done such as removing polyps during a colonoscopy (polypectomy), endoscopic mucosal resection, and laparoscopic surgery.

Regional Outlooks

The global anal and colorectal cancer market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America has been predicted to dominate the global anal and colorectal cancer market. The high prevalence of anal & colorectal cancer cases in the US along with easy access of US citizens to its treatment due to the well-established health infrastructure of the region is anticipated to drive the growth of this regional market.

Global Anal and Colorectal Cancer Market Growth, by Region 2021-2027

Global Anal and Colorectal Cancer Market Growth, by Region

Asia-Pacific is projected to have a considerable share in the global anal and colorectal cancer market

Asia-Pacific is anticipated to hold a considerable market share in the global anal and colorectal cancer market. The rising geriatric population which is prone to cancer and increasing incidence and prevalence rate of anal and colorectal cancer are the factors that are growing the market demand in the region. As per the report of WHO, in 2020, in the Asia-Pacific region, around 569,186 incidences of colon cancer were recorded, which is 49.6% of total cases across the globe. The reason for more new cases of cancers and mortalities is having the largest population in the region. Besides, around 296,236 mortalities were recorded due to colon cancer in 2020, which was around 51.4%. Apart from this, the number of anal cancer patients in 2020 was 16,645, and mortalities were 8,120 in the region.

Market Players Outlook

The key players of the anal and colorectal cancer market Amgen Inc., Taiho Pharmaceutical Co., Ltd, Abbott Laboratories (Abbott Diagnostics), F.Hoffmann-La Roche Ltd, Quest Diagnostics Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2020, Genomictree Co. Ltd., a South Korea-based company, has announced that its US branch named Promis Diagnosis Inc., gained a fund of around $30.8 million this month. From August 2019, it has secured around $40.8 million in funds for the US-based branch.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global anal and colorectal cancer market.

Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Geography

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
  • 3.1.4. Recent Developments
• 3.2. Key Strategy Analysis

4. Market Determinants

• 4.1. Motivators
• 4.2. Restraints
• 4.3. Opportunities

5. Market Segmentation

• 5.1. Global Anal and Colorectal Cancer Market by Treatment Type
  • 5.1.1. Surgery
  • 5.1.2. Radiation Therapy
  • 5.1.3. Chemotherapy
  • 5.1.4. Targeted Therapy
  • 5.1.5. Immunotherapy
• 5.2. Global Anal and Colorectal Cancer Market by End-User
  • 5.2.1. Hospitals
  • 5.2.2. Ambulatory Surgery Centers
  • 5.2.3. Cancer Research Centers

6. Regional Analysis

• 6.1. North America
  • 6.1.1. United States
  • 6.1.2. Canada
• 6.2. Europe
  • 6.2.1. UK
  • 6.2.2. Germany
  • 6.2.3. Italy
  • 6.2.4. Spain
  • 6.2.5. France
  • 6.2.6. Rest of Europe
• 6.3. Asia-Pacific
  • 6.3.1. China
  • 6.3.2. India
  • 6.3.3. Japan
  • 6.3.4. South Korea
  • 6.3.5. Rest of Asia-Pacific
• 6.4. Rest of the World

7. Company Profiles

• 7.1. Abbott Laboratories (Abbott Diagnostics)
• 7.2. Advaxis, Inc.
• 7.3. Amgen Inc.
• 7.4. Atara Biotherapeutics, Inc.
• 7.5. Bayer AG
• 7.6. Beckman Coulter, Inc.
• 7.7. Boehringer Ingelheim International GmbH
• 7.8. Clinical Genomics Technologies Pvt. Ltd.
• 7.9. EDP Biotech Corp.
• 7.10. Eli Lilly and Co. **List not exhaustive

LIST OF TABLES

• 1. GLOBAL ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
• 2. GLOBAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 3. GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 4. GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 5. GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 6. GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 7. GLOBAL ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 8. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 9. GLOBAL AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 10. GLOBAL CANCER RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 11. NORTH AMERICAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 12. NORTH AMERICAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
• 13. NORTH AMERICAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 14. NORTH AMERICAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
• 15. EUROPEAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 16. EUROPEAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
• 17. EUROPEAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 18. EUROPEAN ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
• 19. ASIA-PACIFIC ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 20. ASIA-PACIFIC ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
• 21. ASIA-PACIFIC ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 22. ASIA-PACIFIC ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
• 23. REST OF THE WORLD ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 24. REST OF THE WORLD ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
• 25. REST OF THE WORLD ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
• 26. REST OF THE WORLD ANAL AND COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL ANAL AND COLORECTAL CANCER MARKET SHARE BY END USER, 2020 VS 2027 (%)
• 2. GLOBAL ANAL AND COLORECTAL CANCER MARKET SHARE BY TREATMENT TYPE, 2020 VS 2027 (%)
• 3. GLOBAL ANAL AND COLORECTAL CANCER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
• 4. GLOBAL RADIATION THERAPY IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 5. GLOBAL CHEMOTHERAPY IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 6. GLOBAL TARGETED THERAPY IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 7. GLOBAL IMMUNOTHERAPY IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 8. GLOBAL HOSPITALS SEGMENT IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 9. GLOBAL AMBULATORY SURGERY CENTRES SEGMENT IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 10. GLOBAL CANCER RESEARCH CENTERS IN ANAL AND COLORECTAL MARKET SHARE BY REGION, 2020 VS 2027 (%)
• 11. US ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 12. CANADA ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 13. UK ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 14. FRANCE ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 15. GERMANY ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 16. ITALY ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 17. SPAIN ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 18. REST OF EUROPE ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 19. INDIA ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 20. CHINA ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 21. JAPAN ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 22. SOUTH KOREA ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 23. REST OF ASIA-PACIFIC ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)
• 24. REST OF THE WORLD ANAL AND COLORECTAL CANCER MARKET SIZE, 2020-2027 ($ MILLION)